Boston Partners
GMED icon

Boston Partners’s Globus Medical GMED Stock Holding History

Boston Partners’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$123M Buy
+1,554,990
New +$132M 0.11% 207
2018
Q3 		– Sell
-16,955
Closed -$856K – 731
2018
Q2 		$856K Buy
+16,955
New +$884K ﹤0.01% 754

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Boston Partners's GMED Position: Q2 2026 in Review

Boston Partners opened a new position in Globus Medical (GMED) in Q2 2026: 1,554,990 shares worth $123M. The stake represents 0.11% of the portfolio and ranks #207 among its holdings. This is a return to the name: Boston Partners previously reported a position in GMED as recently as Q2 2018.

Boston Partners first reported a position in GMED in Q2 2018 and has held it in 2 quarters since. 597 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Boston Partners held 1,554,990 shares of Globus Medical worth $123M as of Q2 2026.
  • Globus Medical was a new Boston Partners position in Q2 2026.
  • Globus Medical made up 0.11% of Boston Partners's portfolio in Q2 2026, its #207 holding.
  • Boston Partners first reported a position in Globus Medical in Q2 2018 and has held it in 2 quarters since.
  • 597 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Boston Partners's 13F filing for Q2 2026, filed 4 Aug 2026.